Over time, we may see the cost going down, but right now these products are making a lot of money for these companies. Novo Nordisk ends Hims & Hers deal Novo Nordisk entered a partnership with Hims & Hers in April to make Wegovy more accessible to consumers, but ended the deal on Monday over claims the telehealth firm sold knockoff versions that put patient health at risk
Snel beschikbaar en direct inzetbaar
Acknowledgments The authors acknowledge the infrastructure and staff support provided by the School of Biomedical Sciences and CHRI, Faculty of Health Sciences Curtin University
Three different tests: Tendon outgrowth , how many cells grow out from a piece of tendon in the dish Wound healing assay , cells are grown as a monolayer, you make a scratch in it and observe how quickly it closes Cell survival , you add peroxide (oxidative stress, which normally kills cells) and observe how many survive What they found: Tenocytes grew faster and in a dose-dependent curve (the more BPC-157, the more growth) The scratch closed 1.8 faster at 1 g/ml BPC-157 Under oxidative stress, 22 % of cells survived without BPC-157, but 67 % with BPC-157 When they blocked the FAK enzyme, the effect disappeared mechanism confirmed Why it matters: This is not just a systemic effect via blood, BPC-157 directly modifies the biology of an individual cell
You joined programs
USA Glutathione Supplements Market Analysis The USA glutathione supplements market is projected to grow at a CAGR of 6.8% from 2025 to 2035